| 000 | 01389 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515202524.0 | ||
| 264 | 0 | _c20100608 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0b013e3283363980 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Xiaowei | |
| 245 | 0 | 0 |
_aReversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cApr 2010 |
||
| 300 |
_a381-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
| 650 | 0 | 4 |
_aRepressor Proteins _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aThrombospondin 1 _xmetabolism |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aLi, Wei | |
| 700 | 1 | _aTan, Guolin | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 21 _gno. 4 _gp. 381-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0b013e3283363980 _zAvailable from publisher's website |
| 999 |
_c19431049 _d19431049 |
||